RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Albany, NY · Laurelton, NY · Long Island City, NY · +53 more sites
Obesity clinical trials in Long Island City, NY
4 recruiting obesity studies with a site in Long Island City, NY.
RecruitingPhase 2NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Sponsor: Eli Lilly and Company
Long Island City, NY · Staten Island, NY · West Seneca, NY · +22 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Hartsdale, NY · Long Island City, NY · Rochester, NY · +77 more sites
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Long Island City, NY · New York, NY · +52 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.